{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:15:58Z","timestamp":1793128558069,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"am","delay-in-days":298,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS-093990"],"award-info":[{"award-number":["NS-093990"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-007024"],"award-info":[{"award-number":["T32-007024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neuropharm.2024.110165","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T08:56:03Z","timestamp":1726649763000},"page":"110165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Dissociation between the anti-allodynic effects of fingolimod (FTY720) and desensitization of S1P1 receptor-mediated G-protein activation in a mouse model of sciatic nerve injury"],"prefix":"10.1016","volume":"261","author":[{"given":"Abby M.","family":"Pondelick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3545-9594","authenticated-orcid":false,"given":"Lauren V.","family":"Moncayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Donvito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9406-8924","authenticated-orcid":false,"given":"Virginia D.","family":"McLane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7237-4568","authenticated-orcid":false,"given":"James C.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7886-0332","authenticated-orcid":false,"given":"Kurt F.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron H.","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Sim-Selley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana E.","family":"Selley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.neuropharm.2024.110165_bib1","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.pain.2012.06.005","article-title":"Regulatory T cells attenuate neuropathic pain following peripheral nerve injury and experimental autoimmune neuritis","volume":"153","author":"Austin","year":"2012","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110165_bib2","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/jnc.14985","article-title":"Role of 1-Deoxysphingolipids in docetaxel neurotoxicity","volume":"154","author":"Becker","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2024.110165_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2024.110165_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuroscience.2018.04.020","article-title":"Longitudinal structural and functional brain network alterations in a mouse model of neuropathic pain","volume":"387","author":"Bilbao","year":"2018","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110165_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"24","key":"10.1016\/j.neuropharm.2024.110165_bib6","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.C200176200","article-title":"The immune modulator FTY720 targets sphingosine 1-phosphate receptors","volume":"277","author":"Brinkmann","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110165_bib7","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1194\/jlr.M065920","article-title":"ORMDL proteins regulate ceramide levels during sterile inflammation","volume":"57","author":"Cai","year":"2016","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.neuropharm.2024.110165_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/2058738419838383","article-title":"The neuropathic pain: an overview of the current treatment and future therapeutic approaches","volume":"33","author":"Cavalli","year":"2019","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110165_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"issue":"21","key":"10.1016\/j.neuropharm.2024.110165_bib10","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1073\/pnas.1820466116","article-title":"Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain","volume":"116","author":"Chen","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110165_bib11","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1152\/jn.00709.2010","article-title":"The sphingosine 1-phosphate receptor, S1PR1, plays a prominent but not exclusive role in enhancing the excitability of sensory neurons","volume":"104","author":"Chi","year":"2010","journal-title":"J. Neurophysiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110165_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.1014154108","article-title":"FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation","volume":"108","author":"Choi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"47","key":"10.1016\/j.neuropharm.2024.110165_bib13","doi-asserted-by":"crossref","first-page":"32442","DOI":"10.1074\/jbc.M806410200","article-title":"Sphingosine 1-phosphate modulates spinal nociceptive processing","volume":"283","author":"Coste","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110165_bib14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1582-4934.2008.00160.x","article-title":"Antinociceptive activity of the S1P\u2010receptor agonist FTY720","volume":"12","author":"Coste","year":"2008","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110165_bib15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/j.pain.0000000000001106","article-title":"Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn","volume":"159","author":"Doolen","year":"2018","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110165_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.pain.2010.12.011","article-title":"Role for peroxynitrite in sphingosine-1-phosphate-induced hyperalgesia in rats","volume":"152","author":"Doyle","year":"2011","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110165_bib17","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jpain.2019.02.007","article-title":"Activation of sphingosine-1-phosphate receptor 1 in the spinal cord produces mechanohypersensitivity through the activation of inflammasome and IL-1\u03b2 pathway","volume":"20","author":"Doyle","year":"2019","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2024.110165_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynpai.2019.100034","article-title":"Alterations in brain neurocircuitry following treatment with the chemotherapeutic agent paclitaxel in rats","volume":"6","author":"Ferris","year":"2019","journal-title":"Neurobiol. Pain"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110165_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.107.127183","article-title":"Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis","volume":"323","author":"Foster","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110165_bib20","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/j.pain.0000000000000965","article-title":"Targeting the S1P\/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation","volume":"158","author":"Grenald","year":"2017","journal-title":"Pain"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.110165_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2013.02.011","article-title":"Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy","volume":"328","author":"Groves","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110165_bib22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nn.3728","article-title":"Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory","volume":"17","author":"Hait","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110165_bib23","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/bph.12207","article-title":"Pathway specific modulation of S1P1 receptor signalling in rat and human astrocytes","volume":"169","author":"Healy","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110165_bib24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/jpet.114.222315","article-title":"Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in Mices","volume":"353","author":"Ignatowska-Jankowska","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110165_bib25","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41590-024-01857-2","article-title":"Nociceptor-immune interactomes reveal insult-specific immune signatures of pain","volume":"25","author":"Jain","year":"2024","journal-title":"Nat. Immunol."},{"issue":"30","key":"10.1016\/j.neuropharm.2024.110165_bib26","doi-asserted-by":"crossref","first-page":"21082","DOI":"10.1074\/jbc.M114.569574","article-title":"The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1","volume":"289","author":"Janes","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.neuropharm.2024.110165_bib27","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1021\/acschemneuro.1c00492","article-title":"In vitro and in vivo investigation of S1PR1 expression in the central nervous system using [3H]CS1P1 and [11C]CS1P1","volume":"12","author":"Jiang","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110165_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1179\/014788813X13756994210382","article-title":"Comparison of standard laminectomy with an optimized ejection method for the removal of spinal cords from rats and mice","volume":"36","author":"Kennedy","year":"2013","journal-title":"J. Histotechnol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110165_bib29","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/jpet.109.155465","article-title":"Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain","volume":"330","author":"Kinsey","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"8\u20139","key":"10.1016\/j.neuropharm.2024.110165_bib30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.lfs.2012.08.023","article-title":"Brain regional differences in CB1 receptor adaptation and regulation of transcription","volume":"92","author":"Lazenka","year":"2013","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110165_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-015-0286-8","article-title":"Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and\/or 3","volume":"12","author":"Li","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110165_bib32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni.1743","article-title":"The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR","volume":"10","author":"Liu","year":"2009","journal-title":"Nat. Immunol."},{"issue":"7503","key":"10.1016\/j.neuropharm.2024.110165_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"issue":"5566","key":"10.1016\/j.neuropharm.2024.110165_bib34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2024.110165_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108885","article-title":"Sphingosine-1-phosphate receptor 1 agonist SEW2871 alters membrane properties of late-firing somatostatin expressing neurons in the central lateral amygdala","volume":"203","author":"Mork","year":"2022","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110165_bib36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nchembio.173","article-title":"Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors","volume":"5","author":"Mullershausen","year":"2009","journal-title":"Nat. Chem. Biol."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110165_bib37","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1046\/j.1460-9568.1999.00641.x","article-title":"Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice","volume":"11","author":"Murphy","year":"1999","journal-title":"Eur. J. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110165_bib38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biopsych.2011.11.027","article-title":"\u03b2-Arrestin2 regulates cannabinoid CB 1 receptor signaling and adaptation in a central nervous system region-dependent manner","volume":"71","author":"Nguyen","year":"2012","journal-title":"Biol. Psychiatr."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110165_bib39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1369\/jhc.2010.956409","article-title":"Cellular localization of sphingosine-1-phosphate receptor 1 expression in the human central nervous system","volume":"58","author":"Nishimura","year":"2010","journal-title":"J. Histochem. Cytochem."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110165_bib40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nchembio.767","article-title":"Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin","volume":"8","author":"Patti","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110165_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1124\/mol.105.020552","article-title":"Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4- octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor","volume":"70","author":"Paugh","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110165_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.15585\/mmwr.mm7215a1","article-title":"Chronic pain among adults \u2014 United States, 2019\u20132021","volume":"72","author":"Rikard","year":"2023","journal-title":"Morb. Mortal. Wkly. Rep."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110165_bib43","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.4049\/jimmunol.175.12.7973","article-title":"The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+\/CD25+ T-regulatory cells and enhances their functional activity","volume":"175","author":"Sawicka","year":"2005","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110165_bib44","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neuroimage.2009.05.068","article-title":"MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain","volume":"47","author":"Seminowicz","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2024.110165_bib45","first-page":"7242","article-title":"In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5\u2019-[gamma-[35S]thio]-triphosphate binding","volume":"92","author":"Sim","year":"1995","journal-title":"Neurobiology"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110165_bib46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1615\/CritRevNeurobiol.v15.i2.10","article-title":"Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids","volume":"15","author":"Sim-Selley","year":"2003","journal-title":"Crit. Rev. Neurobiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110165_bib47","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.2009.06202.x","article-title":"Sphingosine-1-phosphate receptors mediate neuromodulatory functions in the CNS","volume":"110","author":"Sim-Selley","year":"2009","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110165_bib48","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.bjp.0707328","article-title":"Region-dependent attenuation of \u03bc opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance","volume":"151","author":"Sim-Selley","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110165_bib49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1124\/jpet.118.248260","article-title":"Differential tolerance to FTY720-induced antinociception in acute thermal and nerve injury mouse pain models: role of sphingosine-1-phosphate receptor adaptation","volume":"366","author":"Sim-Selley","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110165_bib50","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/glia.24135","article-title":"Neuronal contact upregulates astrocytic sphingosine-1-phosphate receptor 1 to coordinate astrocyte-neuron cross communication","volume":"70","author":"Singh","year":"2022","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110165_bib51","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1084\/jem.20170584","article-title":"Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain","volume":"215","author":"Stockstill","year":"2018","journal-title":"J. Exp. Med."},{"issue":"41","key":"10.1016\/j.neuropharm.2024.110165_bib52","article-title":"Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation","volume":"10","author":"Wu","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"15","key":"10.1016\/j.neuropharm.2024.110165_bib53","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1089\/neu.2019.6905","article-title":"FTY720 attenuates neuropathic pain after spinal cord injury by decreasing systemic and local inflammation in a rat spinal cord compression model","volume":"37","author":"Yamazaki","year":"2020","journal-title":"J. Neurotrauma"},{"issue":"6\u20137","key":"10.1016\/j.neuropharm.2024.110165_bib54","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1515\/hsz-2014-0276","article-title":"Antinociceptive effects of FTY720 during trauma-induced neuropathic pain are mediated by spinal S1P receptors","volume":"396","author":"Zhang","year":"2015","journal-title":"Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110165_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2249.2009.03942.x","article-title":"Immunomodulatory drug FTY720 induces regulatory CD4+CD25 + T cells in vitro","volume":"157","author":"Zhou","year":"2009","journal-title":"Clin. Exp. Immunol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T03:57:39Z","timestamp":1730865459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824003344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":55,"alternative-id":["S0028390824003344"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110165","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dissociation between the anti-allodynic effects of fingolimod (FTY720) and desensitization of S1P1 receptor-mediated G-protein activation in a mouse model of sciatic nerve injury","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110165"}}